HB7801, the Cloud Labs to Advance Biotechnology Act of 2026, would direct the National Science Foundation to establish and run a pilot cloud laboratory network focused on biotechnology. The bill defines “cloud laboratories” as physical labs equipped with advanced instrumentation and robots that can be remotely controlled by scientists to run continuous experiments and generate biological data. It also defines related terms such as authorized researcher, biological data, phase II cloud laboratory, and phase III cloud laboratory.
The core of the bill requires NSF, in consultation with the Department of Energy and the National Institute of Standards and Technology, to create a national cloud laboratory network within 360 days and submit an implementation plan to Congress. That plan must assess existing public and private cloud labs, describe how the network will be organized, explain how data will be stored and shared, outline access and payment models, propose sample intellectual property agreements, and address cybersecurity, biosecurity, and research security. The bill also creates a cloud laboratory advisory board with members from federal agencies, academia, biosafety and ethics fields, and industry to guide data priorities, access rules, and safeguards.
The bill would then authorize competitive grants for at least two phase II cloud laboratories within two years and at least three additional phase III cloud laboratories within four years, with each award lasting multiple years. These labs would be expected to generate high-quality biological data for use by authorized researchers, including for training artificial intelligence models and supporting other biological data analysis, while also giving researchers access to advanced experimental infrastructure. The bill requires annual reporting to Congress on progress and sunsets the pilot program after 12 years.
The bill’s impact on state laws is indirect, because it does not amend state statutes or create state-level mandates. Instead, it expands federal research infrastructure and NSF authority, potentially affecting universities, private biotechnology firms, government labs, and researchers that seek access to federally supported cloud lab networks and data. It also creates new federal planning, reporting, and advisory requirements around data governance, intellectual property, and security practices in biotechnology research.
No committee transcript or vote record was provided, so there is no recorded floor or committee sentiment to assess. Based on the bill text alone, the measure appears generally innovation-focused and supportive of biotechnology research, AI-enabled science, and broader access to advanced lab infrastructure. The main likely points of contention are access and pricing for proprietary versus nonproprietary users, intellectual property treatment, data sharing rules, and the adequacy of cybersecurity, biosecurity, and research-security safeguards.
HB7801 would expand federal research infrastructure by directing NSF to establish a cloud laboratory network and award grants for multiple cloud labs over a 12-year pilot period. It would not directly change state law, but it would affect federal research funding, biotechnology data governance, and access to advanced lab facilities for universities, companies, and government labs. The bill also imposes new federal reporting, advisory, and planning requirements on NSF and related agencies.
No votes or committee discussion were provided, so there is no recorded legislative sentiment to summarize. On its face, the bill reflects a pro-innovation, pro-research posture, with bipartisan sponsorship and a focus on biotechnology, AI, and shared scientific infrastructure. The overall tone of the measure is constructive and forward-looking, though it anticipates careful oversight of security and access issues.
The most likely areas of contention are how cloud laboratory access will be priced and allocated, how nonproprietary users will receive no- or low-cost access, and how industry subscription models will work. Another likely issue is intellectual property: the bill requires sample IP agreements but leaves details to be developed later, which could raise concerns among academic and commercial stakeholders. Security is also a major focus, and some may argue over whether the proposed safeguards for cybersecurity, biosecurity, and research security are sufficient while still allowing broad access to researchers across institution types.